OutSense Company Profile

Background

OutSense, founded in 2016 and headquartered in Or Yehuda, Israel, is a digital health startup specializing in the development of IoT devices designed to analyze human waste for early detection of medical conditions. The company's mission is to transform routine bathroom visits into opportunities for health monitoring, thereby enabling timely interventions and improving patient outcomes. By integrating advanced sensor technology with artificial intelligence, OutSense aims to revolutionize non-invasive health diagnostics, particularly in the early detection of colorectal cancer and monitoring of conditions prevalent among the elderly.

Key Strategic Focus

OutSense's strategic focus centers on the development and deployment of its proprietary IoT device that attaches to standard toilet bowls. This device utilizes multi-spectral optical sensors and AI-driven analysis to detect signs of colorectal cancer, dehydration, urinary tract infections, constipation, and diarrhea. The company targets healthcare providers, elderly care facilities, and individual consumers, emphasizing the importance of continuous, non-invasive health monitoring to facilitate early detection and intervention.

Financials and Funding

OutSense has successfully secured a total of $2.7 million in funding. In November 2020, the company raised $2.2 million in a Series A round led by Peregrine Ventures, aimed at completing product development and expanding medical trials. In June 2021, Longevity Venture Partners invested an additional $500,000, bringing the total Series A funding to $2.7 million. These funds have been allocated towards product development, clinical trials, and preparations for large-scale production.

Pipeline Development

OutSense's primary product is its IoT device designed for attachment to standard toilet bowls, enabling the detection of various health conditions through waste analysis. The device has demonstrated 90% accuracy in detecting hidden blood in stool, a key indicator of colorectal cancer, as validated in clinical studies at Israel's Meir Medical Center. The company has initiated clinical trials in Israel, including a study with Tel Aviv's Sourasky Medical Centre involving 50 patients, and plans to commence pilot programs in the United States and Japan. These initiatives aim to validate the device's efficacy in real-world settings and support regulatory approval processes.

Technological Platform and Innovation

OutSense's innovation lies in its integration of multi-spectral optical sensors with AI-driven analysis to non-invasively monitor human waste. The device captures optical samples automatically, transmitting data to the cloud for real-time analysis using proprietary computer vision algorithms. This approach enables the detection of hidden blood in stool, dehydration, urinary tract infections, and other health indicators without active user intervention. The technology has been granted patents in the U.S., Europe, Japan, and China, underscoring its novelty and potential impact in the field of health diagnostics.

Leadership Team

Yfat Scialom: Chief Executive Officer and Board Member. Ms. Scialom has been instrumental in steering OutSense's strategic direction and fostering partnerships to advance the company's mission.

Ishay Attar: Founder and Chairman. Mr. Attar's vision and leadership have been foundational in establishing OutSense's innovative approach to health diagnostics.

Yaara Kapp-Barnea, Ph.D.: Chief Technology Officer. Dr. Kapp-Barnea oversees the technological development and integration of OutSense's products.

Tali Triebitz, Ph.D.: Chief Scientific Officer. Dr. Triebitz leads the scientific research and validation efforts, ensuring the efficacy and reliability of OutSense's diagnostic solutions.

Leadership Changes

As of the latest available information, there have been no recent significant changes or appointments within OutSense's leadership team.

Competitor Profile

Market Insights and Dynamics

The health diagnostics market, particularly in non-invasive monitoring technologies, is experiencing significant growth. The increasing emphasis on early detection and preventive healthcare, coupled with advancements in IoT and AI technologies, has created a fertile ground for innovative solutions like those offered by OutSense. The aging global population further amplifies the demand for continuous health monitoring solutions, positioning OutSense favorably within this expanding market.

Competitor Analysis

OutSense operates in a competitive landscape with several notable companies:

Aloe Care Health: Provides medical alert services through technology solutions aimed at elderly care.

Itamar Medical: Specializes in medical devices for diagnosing sleep apnea and heart conditions.

SensoGenic: Develops solutions for detecting food allergies.

Elaborate: Offers electronic health record management solutions.

While these companies focus on various aspects of health monitoring and diagnostics, OutSense's unique approach to analyzing human waste for early disease detection sets it apart in the market.

Strategic Collaborations and Partnerships

OutSense has established significant partnerships to advance its technology and market reach:

Longevity Venture Partners: Invested in OutSense and initiated a pilot program in collaboration with CommuniCare Family of Companies, a major U.S. healthcare enterprise with over 90 facilities.

Clinical Trials: Conducting trials in Israel, including a study with Tel Aviv's Sourasky Medical Centre, and planning pilots in Japan to validate the device's efficacy in diverse populations.

These collaborations are pivotal in validating OutSense's technology and facilitating its entry into international markets.

Operational Insights

OutSense's strategic positioning leverages its innovative technology to address unmet needs in non-invasive health diagnostics. The company's focus on early detection of colorectal cancer and monitoring of conditions prevalent among the elderly provides a distinct competitive advantage. By integrating seamlessly into daily routines without requiring active user participation, OutSense enhances user compliance and data reliability, setting it apart from traditional diagnostic methods.

Strategic Opportunities and Future Directions

Looking ahead, OutSense aims to expand its product offerings to detect a broader range of health conditions through waste analysis. The company plans to pursue regulatory approvals, including FDA clearance, to